Thomas Christoph
37Patents
7h-index
51Co-inventors
68Inventor score
Filing activity: Sep 3, 1998 → May 23, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8642623B2 | Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions | Chemistry; Metallurgy | 14 | Active |
| US6660774B2 | Use of (+)-tramadol, O-demethyltramadol or (+)-O-demethyl-tramadol, O-desmethyl-N-mono-desmethyl-tramadol or (+)- O-desmethyl-N-mono-desmethyltramadol | Human Necessities | 13 | Expired |
| US7625900B2 | Sutstituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain | Human Necessities | 12 | Active |
| US8084484B2 | Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions | Chemistry; Metallurgy | 10 | Active |
| US8252816B2 | Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions | Chemistry; Metallurgy | 10 | Active |
| US8017772B2 | Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain | Human Necessities | 9 | Active |
| US7879858B2 | Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions | Human Necessities | 9 | Active |
| US7420056B2 | Substituted bicyclic imidazo-3-ylamine compounds | Human Necessities | 5 | Active |
| US6004948A | Derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II | Chemistry; Metallurgy | 5 | Expired |
| US8710233B2 | Vanilloid receptor ligands and use thereof for the production of pharmaceutical preparations | Chemistry; Metallurgy | 5 | Active |
| US6908944B2 | Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence | Human Necessities | 4 | Expired |
| US7008939B2 | Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence | Human Necessities | 3 | Expired |
| US8536130B2 | Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain | Human Necessities | 3 | Active |
| US6342517B1 | Potassium channel activators and their use | Human Necessities | 3 | Expired |
| US8334315B2 | Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands | Chemistry; Metallurgy | 3 | Active |
| US9320725B2 | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid | Human Necessities | 2 | Active |
| US8642775B2 | Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions | Chemistry; Metallurgy | 1 | Active |
| US6841575B2 | Use of 1-phenyl-3-dimethylaminopropane compounds for treatment of urinary incontinence | Human Necessities | 1 | Expired |
| US9629825B2 | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid | Human Necessities | 1 | Active |
| US8592471B2 | Substituted phenylureas and phenylamides as vanilloid receptor ligands | Chemistry; Metallurgy | 1 | Active |
| US7361690B2 | Compositions and methods for the treatment of urinary incontinence | Human Necessities | 1 | Expired |
| US9120756B2 | Substituted phenylureas and phenylamides as vanilloid receptor ligands | Chemistry; Metallurgy | 1 | Active |
| US8946290B2 | Combination of selected opioids with muscarine antagonists for treating urinary incontinence | Human Necessities | 1 | Active |
| US10206890B2 | Pharmaceutical combination | Human Necessities | 0 | Active |
| US8435978B2 | Substituted sulfonamide compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.